Baxalta (Now Shire) Work Values

Daily Duties at Baxalta (Now Shire):

Initially recruited by Executive VP for Commercial Strategies and Customer Operations to assist in the start-up of a global, independent orphan and specialty biotechnology company (Baxalta) to prepare launch materials, gain market access, and ensure patient access to Hemophilia and bleeding disorder products generating $6 Billion in revenues. Retained and promoted following spin-off of Baxalta, charged with managing 12 direct and 27 indirect reports across the globe, including Canada, Euorpe, Middle East / Africa and Japan with direct accountability for negotiating pricing and reimbursement attainment with government and commercial payers, and presenting value evidence to health technology assessment organizations. Administered a $5 million budget. Coordinated cross-functional activities for market access activities, including clinical development, commercial, medical affairs, health economic and outcomes research, government affairs and public policy, pricing and reimbursement, tenders management and patient advocacy activities to support the launch of four products, six marketed products and five products in clinical development. Conducted payer / pricing research and European advisory board to develop value engagement tools, including health economic models, value dossiers, and payer engagement slide decks and publications.

What they like about Baxalta (Now Shire):

Working in an organization that is technologically advanced, creative, and innovative is critical in your assessment of hiring companies. Less important to you are stability of the organization, the length of time an organization has been in business, and the business' plans for the future. You prefer a fast-moving company that will take risks to achieve its goals and objectives. The length of time the company has been in business is irrelevant. Maintaining status quo is unnecessary. You thrive on change, uncertainty and the upside of potential business risks, especially those associated with innovation. Stability for the long haul is not nearly as important as is working in an atmosphere that is charged with a sense of urgency and constant change.

Tags

Pricing, Pharmaceutical, Oncology, Licensing, Consulting, Research, Urology, Market Access, Patient Access, Outcomes Research, Health Economics, Neuroscience, Boston, Cambridge, Pharmaceutical Administration, Device, Biotechnology, Health Technology Assessment, Marketing, Policy, clinical trials, clinical research

Skills

Global Market Access, Health Economics

These are some of the questions we asked our climbers about their experiences with Baxalta (Now Shire):